And raise of guidance. Up 6% to 90$.
I had thought to put this money elsewhere but they preannounced good results so figure today would be good news and it was.
I have not calculated new PE’s, 1YPEG’s and such yet.
7:05 am Abiomed beats by $0.07, reports revs in-line; guides Q4 revs above estimate; guides FY16 revs above consensus (ABMD) :
Reports Q3 (Dec) earnings of $0.23 per share, $0.07 better than the Capital IQ Consensus of $0.16; revenues rose 38.4% year/year to $85.8 mln vs the $85.81 mln single analyst estimate.
Co issues upside guidance for Q4, sees Q4 revs of $90 mln vs. $88.17 mln single analyst estimate.
Co issues upside guidance for FY16, sees FY16 revs of $326 mln vs. $315.17 mln Capital IQ Consensus Estimate, up from prior guidance of $305-315 mln. Co also increases its FY16 guidance for GAAP operating margin to “greater than 17%”, updated from the previous guidance range of 15% to 17%.